Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Staehelin Thomas
 2. Date of Event Requiring Statement (Month/Day/Year)
07/02/2007		 3. Issuer Name and Ticker or Trading Symbol
MYMETICS CORP [OTCBB:MYMX]
(Last)
(First)
(Middle)
ROUTE DE LA CORNICHE, 4		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

EPALINGES, V8 CH-1066		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common stock 12,479,907
I
By Eardley Holding A.G. (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Unsecured convertible note, 6/23/2006   (2)   (2) Common stock 190,000 (2) $ 0.1 I By Eardley Holding A.G. (1)
Secured convertible note, 6/15/2009   (3)   (3) Common stock 143,000 $ 0.8 I By Eardley Holding A.G. (1)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Staehelin Thomas
ROUTE DE LA CORNICHE, 4
EPALINGES, V8 CH-1066		   X      

Signatures

/s/ Thomas Staehelin 12/20/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Mr. Staehelin is the sole owner of Eardley Holding A.G.
(2) The unsecured convertible note was issued on 6/23/2006 in the original principal amount of $190,000. This note bears interest at the rate of 10% per annum. Principal and accrued interest are convertible into shares of common stock at any time at a conversion price of $0.10 per share. This note matures upon the earlier of (i) the date the Issuer has sufficient revenues to pay or (ii) upon an event of default.
(3) The secured convertible note was issued on 6/15/2009 in the original principal amount of $143,000. This note bears interest at the rate of 10% per annum. Principal and accrued interest are convertible into shares of common stock at any time at a conversion price of $0.10 per share. This note matures upon the earlier of (i) the date the Issuer has sufficient revenues to pay or (ii) upon an event of default. The note is secured by shares of Bestewil Holding BV, the company that owned all the issued and outstanding shares of Mymetics BV, formerly Virosome Biologicals BV.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.